Some human cancers have been reported to have a high level of PCK2 expression9–11, but it is in hepatocellular carcinoma that PCK2 expression is down-regulated, and low PCK2 expression is likely connected with a bad prognosis in HCC patients. Here, PCK2 is linked to hepatocellular carcinoma.